about
Coarse-grained modeling of mucus barrier propertiesNotable Aspects of Glycan-Protein InteractionsMucus penetrating nanoparticles: biophysical tool and method of drug and gene deliveryAdvances in HIV microbicide developmentIncreases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive TractEffect of Native Gastric Mucus on in vivo Hybridization Therapies Directed at Helicobacter pylori.Nanoparticle transport from mouse vagina to adjacent lymph nodesSize selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipidsTransport of particles in intestinal mucus under simulated infant and adult physiological conditions: impact of mucus structure and extracellular DNAEnzymatically active biomimetic micropropellers for the penetration of mucin gels.Airway hydration and COPDMammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterialsHighly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapyFunctionalized positive nanoparticles reduce mucin swelling and dispersionTransport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucusThe interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticlesDiffusion through Pig Gastric Mucin: Effect of Relative HumidityBarriers to inhaled gene therapy of obstructive lung diseases: A reviewCoated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.Progress in antiretroviral drug delivery using nanotechnologyThe importance of the vaginal delivery route for antiretrovirals in HIV prevention.Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs.Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen.Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.Hierarchical nanoengineered surfaces for enhanced cytoadhesion and drug deliveryAn exploration of the microrheological environment around the distal ileal villi and proximal colonic mucosa of the possum (Trichosurus vulpecula).Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriersAdhesion of the genome-sequenced Lactococcus lactis subsp. cremoris IBB477 strain is mediated by specific molecular determinants.Microstructural alterations of sputum in cystic fibrosis lung disease.Model demonstrates functional purpose of the nasal cycle.Side chain variations radically alter the diffusion of poly(2-alkyl-2-oxazoline) functionalised nanoparticles through a mucosal barrier.Adsorption of human papillomavirus 16 to live human sperm.Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects.Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.Methanol leaf extract of Actinodaphne sesquipedalis (Lauraceae) enhances gastric defense against ethanol-induced ulcer in rats.Do viruses use vectors to penetrate mucus barriers?Airway mucus function and dysfunction.Synthetic oral mucin mimic from polymer micelle networks.Nanoparticle-based drug delivery to the vagina: a review.Controlled release for local delivery of drugs: barriers and models.
P2860
Q24606537-9D1F254C-6EAD-4AC7-BF87-BD5BF77F93C3Q26784159-78352CE6-06CA-463E-A47E-4ACB33FD5BB8Q26823541-CBAC131E-4B80-4553-ACFE-B9F9378376F1Q26852858-C6D02505-7C51-43F9-85D6-E4BE7B5539D2Q27311833-14401C1D-C0F3-470F-A0B1-2C5477846B2FQ27317349-3887AC27-3CAA-498B-B410-E79EDF135B8BQ27329123-90497B55-13B7-41A3-AC89-26BA046C37AFQ27334566-1FAB0663-0BB5-467B-9C16-032C4F7DD239Q27336871-C3C1C972-B0AC-4663-9D80-A7020D004386Q27339714-D0FAA9E6-D32F-4FE5-A25B-1A3431EE2533Q28082617-BF0987E3-A027-4D5E-924C-CB80C6381B6DQ28087071-735DAEBB-C008-4529-A004-208634382C3BQ28383844-728B19ED-95D2-4F76-9629-3EA54C279A41Q28384444-38E7360F-8D08-4C8E-9A5E-187D0451BFEFQ28397868-9169F152-E1B9-43FB-AAEE-256B1167D156Q28481207-1E0D0CAA-34DA-4BAF-928B-7FB7EAC19C9FQ28552057-41FC7F62-D099-4CA1-9BF3-36CB209242C2Q29248141-557DFEF0-716B-4784-863C-FB020BEE42C4Q30392895-4F744B30-5203-46CC-958E-FF9EC2154A70Q30395011-FE58FBAE-A173-4435-801F-9DF904ACB97FQ30414890-476E103C-D7FC-4356-93FC-3EEB607D611EQ30451024-72ACA8D0-3C21-4678-A730-9F68CA03332CQ30468622-E051FF0C-1675-496A-8C01-6AE002C3995EQ30499386-820A1F4A-5C4D-457B-8C88-F2C8D50F87BEQ30500042-7B6A8C0D-15A1-42D1-AC1F-9DC35288F257Q30538893-7887A27F-3DFF-4DD0-8689-2100930775E4Q30546346-7F9A27A7-8775-47D7-85BD-CFC316BF8CA5Q30824795-946382A7-A0A3-40A5-91CA-41B66F9CA412Q30826846-E4E3DFEC-050E-479D-AC4D-B9D9C8673BB3Q30938810-A6EB4C4C-58D4-4E7A-993D-DD5E444CCD8DQ31113829-0C50FA38-9E53-4208-B550-64679836379AQ33464965-65DC5485-ABFF-45D2-835E-E711E7101F2BQ33579251-6850A0A3-582F-438E-8871-41348723BF03Q33640386-3DCEE434-775E-4F29-9123-35615F8AACA1Q33649901-338FB535-F629-43BE-AEA6-2531D6F4EFBCQ33680444-574D70FF-88D0-43A2-A89B-AC2A33DFD99CQ33723578-1811A4B9-DA80-4B10-A971-6D5B2DB0F2EEQ34033729-5A90A241-E2FE-4094-98C5-8C503B89D33EQ34079533-2C54DC0F-09BD-422A-A3F1-7C0433083522Q34079560-78D64DFC-0EFF-4053-A1C2-CC668A214C5F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on 16 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Barrier properties of mucus.
@en
Barrier properties of mucus.
@nl
type
label
Barrier properties of mucus.
@en
Barrier properties of mucus.
@nl
prefLabel
Barrier properties of mucus.
@en
Barrier properties of mucus.
@nl
P1476
Barrier properties of mucus.
@en
P2093
Richard A Cone
P356
10.1016/J.ADDR.2008.09.008
P407
P577
2008-12-16T00:00:00Z